A quadruplet regimen for treating transplant-ineligible, newly diagnosed multiple myeloma (MM), combining the oral drug ixazomib with daratumumab, lower-dose lenalidomide, and dexamethasone (Dara-RId) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback